Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team
Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team Cancer, Immunology, Immunotherapy, Lymphocytes, Depletion. Ludovic Martinet Team GENIM Genomic and immunology of myeloma A team from the Centre de Recherches en Cancérologie de...
Heterogeneity in long-term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patients
Heterogeneity in long-term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patients Multiple myeloma, Cytogenetics, Prognosis Anaïs Schavgoulidze – Team GENIM – Genomic and Immunology of myeloma Multiple myeloma (MM) is characterized by...
More news
Very soon more news from this team to follow….
